EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.544
https://www.valueinhealthjournal.com/article/S1098-3015(24)00659-4/fulltext
Section Title :
Section Order :
10024
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00659-4&doi=10.1016/j.jval.2024.03.544